Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Misoprostol vaginal insert - Ferring Pharmaceuticals

Drug Profile

Misoprostol vaginal insert - Ferring Pharmaceuticals

Alternative Names: Misodel; Misopess; Misoprostol CR insert; MVI 100; Mysodelle; Myspess; XP 16J

Latest Information Update: 29 Jul 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Cytokine PharmaSciences
  • Developer Cytokine PharmaSciences; Ferring Pharmaceuticals
  • Class Abortifacients; Antiulcers; Oxytocics; Prostaglandins
  • Mechanism of Action Prostaglandin E1 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Labour induction

Most Recent Events

  • 29 Jul 2019 Misoprostol vaginal insert is not yet available for Labour induction in Bulgaria, Cyprus, Estonia, France, Greece, Hungary, Iceland, Latvia, Lithuania, Luxembourg, Malta, Portugal, Romania, Slovakia, Slovenia, Spain
  • 08 May 2019 Launched for Labour induction in Poland prior May 2019 (Vaginal)
  • 24 Jun 2018 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top